Genetic features of a patient may influence the efficacy and safety profile of a medicinal product

Abstract

Identification of the genetic features that determine a patient’s individual response to a medicinal product and provision of this information to a doctor helps to predict the effectiveness of therapy and the risk of adverse drug reactions. Dmitry A. Sychev — Academician of the Russian Academy of Sciences, Doctor of Medical Sciences, Full Professor, Rector of the Russian Medical Academy of Continuous Professional Education — talks about the importance of a personalised approach to selecting medicinal products and methods for their efficacy and safety control.

Keywords

• pharmacogenetics
• personalised approach
• pharmacogenomics
• efficacy
• drug safety
• adverse drug reactions
• polymorphism
• genetic factors
• pharmacogenetics atlas